CPC A61K 39/42 (2013.01) [A61P 31/16 (2018.01); C07K 16/1018 (2013.01); G01N 33/56983 (2013.01); A61K 2039/505 (2013.01); G01N 2333/11 (2013.01)] | 16 Claims |
1. A method of treating a subject infected with influenza A virus or reducing the likelihood of infection of a subject at risk of contracting influenza A virus, comprising administering to said subject an antibody or antibody fragment having heavy chain CDR1-3 sequences and light chain CDR1-3 sequences of SEQ ID NOS: 17-19 and SEQ ID NOS: 29-31, respectively, or administering an RNA or DNA sequence or vector encoding the antibody or antibody fragment.
|